Literature DB >> 9247320

Effect of angiotensin II on a spinal nociceptive reflex in the rat: receptor and mechanism of action.

N Toma1, V Sgambato, R Couture.   

Abstract

The effect on thermonociceptive threshold of intrathecally (i.t.) administered angiotensin II (Ang II) was assessed in the rat tail-flick test. Rats were pretreated, 15 min earlier, with i.t. naloxone (opiate antagonist), losartan (Ang II selective antagonist at AT1 receptor) or [Sar1, Leu8] Ang II (non selective Ang II receptor antagonist) to define the mechanism of action and the nature of the receptor subtype. Ang II (0.65-6.5 nmol) induced antinociceptive effects that peaked at 1 min post-injection and returned to baseline after 5-10 min. Naloxone (10 microg) completely inhibited the response to 6.5 nmol Ang II. Losartan (65 pmol) and [Sar1, Leu8] Ang II (6.5 nmol) blocked the antinociception induced by Ang II but were inactive against [MePhe7]neurokinin B. Furthermore, losartan failed to affect the hyperalgesic responses induced by substance P (6.5 nmol) or [beta-Ala8]neurokinin A (6.5 nmol). This study provides the first functional evidence that Ang II inhibits the transmission of thermal nociceptive information through an endogenous opioid mechanism and the activation of an AT1 receptor in the rat spinal cord.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247320     DOI: 10.1016/s0024-3205(97)00410-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Involvement of angiotensin II and angiotensin IV in producing the individual characteristics of defensive and feeding behavior in rats.

Authors:  Yu A Prozherina
Journal:  Neurosci Behav Physiol       Date:  2008-07-08

2.  Expression and transport of Angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat.

Authors:  Jaroslav Pavel; Hui Tang; Stephen Brimijoin; Armen Moughamian; Tsuyoshi Nishioku; Julius Benicky; Juan M Saavedra
Journal:  Brain Res       Date:  2008-10-17       Impact factor: 3.252

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.